Search Prime Grants

U19NS132304

Cooperative Agreement

Overview

Grant Description
Preclinical genome editing for rare neurological diseases.
Funding Goals
NOT APPLICABLE
Place of Performance
Bar Harbor, Maine 04609 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 201% from $4,247,547 to $12,795,256.
Jackson Laboratory was awarded Preclinical Genome Editing for Rare Neurological Diseases Cooperative Agreement U19NS132304 worth $12,795,256 from the National Institute of Allergy and Infectious Diseases in May 2023 with work to be completed primarily in Bar Harbor Maine United States. The grant has a duration of 5 years and was awarded through assistance program 93.310 Trans-NIH Research Support. The Cooperative Agreement was awarded through grant opportunity IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed).

Status
(Ongoing)

Last Modified 5/5/25

Period of Performance
5/16/23
Start Date
4/30/28
End Date
41.0% Complete

Funding Split
$12.8M
Federal Obligation
$0.0
Non-Federal Obligation
$12.8M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U19NS132304

Subgrant Awards

Disclosed subgrants for U19NS132304

Transaction History

Modifications to U19NS132304

Additional Detail

Award ID FAIN
U19NS132304
SAI Number
U19NS132304-467978833
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NQ00 NIH National Institute of Neurological Disorders and Stroke
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
XR6LMXNKDJJ1
Awardee CAGE
9N885
Performance District
ME-02
Senators
Susan Collins
Angus King

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Office of the Director, National Institutes of Health, Health and Human Services (075-0846) Health research and training Grants, subsidies, and contributions (41.0) $4,262,002 100%
Modified: 5/5/25